Among patients with axial spondyloarthritis (axSpA) in Singapore, work productivity is lower in the presence of active disease, reduced physical function and poorer quality of life, as reported in a Singapore study.
Radiofrequency ablation and neuromodulation modalities for knee osteoarthritis (OA) potentially improve pain, functionality and disease-specific quality of life for up to 3–12 months with minimal localized complications, according to the results of a systematic review.
Patients with systemic sclerosis appear to have a higher prevalence of lower urinary tract syndrome (LUTS) compared with healthy individuals, with LUTS associated with sarcopaenia, bone damage and calcinosis, suggesting a possible interplay, according to a recent study.
Remission in patients with systemic lupus erythematosus (SLE) is predicted by the absence of mucocutaneous, renal and haematologic involvement, use of immunosuppressive drugs, and lower disease activity state (LDAS) early in the course of the disease, a study has shown. Additionally, older age predicts LDAS.
Patients with psoriatic arthritis (PsA) who avoid physical activity, are younger and are not using biologic agents have a lower risk of enthesis inflammation, suggests a study. Moreover, PsA patients and healthy volunteers aged 35–60 years show similar levels of inflammatory changes of the entheses, but the former have more structural damage.
At 1 year following Roux-en-Y gastric bypass, patients may see an improvement in bone material strength despite an increase in bone turnover and a decline in areal bone mineral density, a recent study has found. While this trend is similar in those with and without type 2 diabetes (T2D), improved glucose control is associated with increased bone material strength among T2D patients.
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.